demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
COVID-19 severe or critically
remdesivir CAP-China ...

1 studies excluded by filtering options 0

5209 SIMPLE (Grein), 0 2300excludednot a RCTrisk of bias not avaialble